Point72 Hong Kong LTD Unity Biotechnology, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.72 - $1.86 $619 - $1,601	-861 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.51 - $9.42 $6,672 - $11,407	-1,211 Reduced 58.45%	861 $5,000
Q4 2020 Feb 16, 2021	SELL	$3.42 - $6.36 $2,007 - $3,733	-587 Reduced 22.08%	2,072 $11,000
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $7,817 - $33,051	2,659 New	2,659 $9,000
Q1 2020 May 15, 2020	SELL	$5.0 - $7.6 $17,830 - $27,101	-3,566 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.99 - $8.38 $21,360 - $29,883	3,566 New	3,566 $26,000
Q2 2019 Aug 14, 2019	SELL	$7.59 - $10.21 $10,087 - $13,569	-1,329 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.65 - $16.66 $10,166 - $22,141	1,329 New	1,329 $11,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.